GERBER STEVEN B 4
4 · CONOR MEDSYSTEMS INC · Filed Feb 2, 2007
Insider Transaction Report
Form 4
GERBER STEVEN B
Director
Transactions
- Disposition to Issuer
Director Stock Option (Right to Buy)
2007-02-01$9.46/sh−6,300$59,598→ 0 totalExercise: $24.04Exp: 2016-06-21→ Common Stock (6,300 underlying) - Disposition to Issuer
Director Stock Option (Right to Buy)
2007-02-01$10.68/sh−33,600$358,848→ 0 totalExercise: $22.82Exp: 2016-01-27→ Common Stock (33,600 underlying) - Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−8,000$268,000→ 0 total(indirect: See Footnote)
Footnotes (4)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated November 16, 2006, among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (the "Merger Agreement"), each issued and outstanding share of common stock was automatically canceled and converted into the right to receive a per share amount equal to $33.50 in cash, without interest.
- [F2]Shares were held by the Gerber Family Trust Steven B. Gerber and Barbara Gerber Trustees 12/13/96.
- [F3]This option, which partially vested in increments of one twelfth of the total shares subject to the option each quarter, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.
- [F4]This option, which vested in increments of one twelfth of the total shares subject to the option each quarter, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.